When I was younger, I wondered if I would live to see this wonderful news. Now I have: The latest generation of malaria vaccines, today being delivered to African children, have efficacy 75–79% in infants a year later (age <18mo.) pubmed.ncbi.nlm.nih.gov/38310910/

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial - PubMed

The Serum Institute of India, the Wellcome Trust, the UK National Institute for Health Research Oxford Biomedical Research Centre, and Open Philanthropy.

Incredible! Wonderful news.

This is wonderful.

When I was younger, I included a malaria vaccine as a joke in a scenario study: link.springer.com/article/10.1...

Vector-Borne Diseases, Development & Climate Change - Integrated Assessment

Vector-borne diseases are feared to extend their range in a future where global warming has occurred. There is considerable concern about scourges such as malaria re-invading currently temperate regio...

Having had malaria myself, and having witnessed its catastrophic effects in Cameroon, I’m going to go ahead and call this a medical miracle.